NPR3 and gastric adenocarcinoma: In addition, NPR3 was also suggested as favorable to prognosis in adrenocortical carcinoma (ACC: HR = 0.83) but not in stomach adenocarcinoma (STAD: HR = 1.15), bladder urothelial carcinoma (BLCA: HR = 1.11), or breast invasive carcinoma (BRCA: HR = 1.10) where it suggested poor prognosis.